![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGWP
RNS Number : 4820E
GW Pharmaceuticals PLC
10 May 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES -------------------------------------------------------------------------------------- 1. Identity of the issuer or the underlying GW Pharmaceuticals PLC issuer of existing shares to which voting rights are attached: (ii) -------------------------------------------------- ---------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ----------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ----------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic x effect to qualifying financial instruments ----------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights ----------------------------------------------------------------------------- ------- Other (please Change of custodian specify): ------------------- -------------------------------------------------------- ------- 3. Full name of person(s) subject Farallon Capital Management L.L.C to the notification obligation: (iii) -------------------------------------------- ---------------------------------------- 4. Full name of shareholder(s) N/A (if different from 3.):(iv) -------------------------------------------- ---------------------------------------- 5. Date of the transaction and date 7 May 2013 on which the threshold is crossed or reached: (v) -------------------------------------------- ---------------------------------------- 6. Date on which issuer notified: 9 May 2013 -------------------------------------------- ---------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% -------------------------------------------- ---------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------ --------------------------------------------- --------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of rights (x) Shares Voting shares Rights ------------ ----------------- -------------------------- --------- ----------------------- --------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------ --- ---- ------ ------- ------ ----- --------- ------------ --------- ------------- ------------ B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. ----------------------- ------------------- ------------------------------ -------------------------- ------------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) ----------------- ---------------- --------------- ---------------- --------------------------- ----------------------- American Nominal Delta depository receipts US36197T1034 ----------------- ---------------- --------------- ---------------- ---- ---------- ----------- 6720000 5.04% ------------------------------------------------------------- --------------------------- ---------- ----------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights --------------------------------------------------------------------- ----------------------------------------------------- 6720000 5.04% --------------------------------------------------------------------- ----------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------------------- 10. Name of the proxy holder: ----------------------------------------------------- ------------------------------- 11. Number of voting rights proxy holder will cease to hold: ----------------------------------------------------- ------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ----------------------------------------------------- ------------------------------- The underlying shares to which the 13. Additional information: ADRs described in section 8. C relate have yet to be admitted to trading on AIM. Consequently, the ADRs are (pending the shares' admission to trading) financial instruments with similar economic effect to a qualifying instrument rather than qualifying financial instruments. When the shares are admitted to trading they will become qualifying financial instruments. ---------------------------------------- -------------------------------------------- 14. Contact name: Elizabeth Wallace ---------------------------------------- -------------------------------------------- 15. Contact telephone number: +1 415 421 2132 ---------------------------------------- --------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEASSEFADDEFF
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions